- Letter
- Published:
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
- Hubert H. M. Van Tol1,3,2,
- James R. Bunzow4,
- Hong-Chang Guan1,
- Roger K. Sunahara1,
- Philip Seeman1,2,
- Hyman B. Niznik1,2,3 &
- …
- Olivier Civelli4
Naturevolume 350, pages610–614 (1991)Cite this article
2050Accesses
15Altmetric
Abstract
DOPAMINE receptors belong to the family of G protein-coupled receptors. On the basis of the homology between these receptors, three different dopamine receptors (D1,D2,D3) have been cloned1–7. Dopamine receptors are primary targets for drugs used in the treatment of psychomotor disorders such as Parkinson's disease and schizophrenia8,9. In the management of socially withdrawn and treatment-resistant schizophrenics, clozapine10 is one of the most favoured antipsychotics because it does not cause tardive dyskinesia11. Clozapine, however, has dissociation constants for binding to D2 and D3 that are 4 to 30 times the therapeutic free concentration of clozapine in plasma water12,13. This observation suggests the existence of other types of dopamine receptors which are more sensitive to clozapine. Here we report the cloning of a gene that encodes such a receptor (D4). The D4 receptor gene has high homology to the human dopamine D2 and D3 receptor genes. The pharmacological characteristics of this receptor resembles that of the D2 and D3 receptors, but its affinity for clozapine is one order of magnitude higher. Recognition and characterization of this clozapine neuroleptic site may prove useful in the design of new types of drugs.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bunzow, J. R.et al.Nature336, 783–787 (1988).
Grandy, D. K.et al.Proc. natn. Acad. Sci. U.S.A.86, 9762–9766 (1989).
Dal Toso, R.et al.EMBO J.8, 4025–4034 (1989).
Zhou, Q-Y.et al.Nature347, 76–80 (1990).
Sunahara, R. K.et al.Nature347, 80–83 (1990).
Dearry, A.et al.Nature347, 72–76 (1990).
Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L. & Schwartz, J.-C.Nature347, 146–151 (1990).
Seeman, P.et al.Neuropsychopharmacology1, 5–15 (1987).
Seeman, P.Synapse1, 152–333 (1987).
Kane, J.et al.Arch. Gen. Psychiat.45, 789–796 (1988).
Casey, D. E.Psychopharmacology99, S47–S53 (1989).
Ackenheil, M., Brau, H., Burkhart, A., Franke, A. & Pacha, W.Arzneimlttel Forsch.26, 1156–1158 (1976).
Clozaril: Summary of Preclinical and Clinical Data (Sandoz Canada. Inc., 1990).
Kozak, M.Nucleic Acids Res.12, 857–872 (1984).
Mount, S. M.Nucleic Acids Res.10, 461–472 (1982).
Dohlman, H. G., Caron, M. G. & Lefkowitz, R. J.Biochemistry26, 2657–2664 (1987).
Hubbard, S. & Ivatt, R.A. Rev. Biochem.50, 555–583 (1981).
Strader, C. D.et al.J. biol. Chem.263, 10267–10271 (1988).
Strader, C. D., Candelore, M. R., Hill, W. S., Sigal, I. S. & Dixon, R. A. F.J. biol. Chem.264, 13572–13578 (1989).
Sibley, D. R., Benovic, J. L., Caron, M. G. & Lefkowitz, R. J.Cell48, 913–922 (1987).
Bouvier, M.et al.Nature333, 370–373 (1988).
O'Dowd, B. F., Hnatowich, M., Caron, M. G., Lefkowitz, R. J. & Bouvier, M.J. biol. Chem.264, 7564–7569 (1989).
Bonner, T. I., Young, A., Brann, M. R. & Buckley, N. J.Neuron1, 403–410 (1988).
Chen, C. & Okayama, H.Molec. cell. Biol.7, 2745–2752 (1987).
Hamer, D. J. & Leder, P. L.Cell18, 1299–1302 (1979).
Gray, P. W. & Goedell, D. V.Proc. natn. Acad. Sci. U.S.A.80, 5842–5846 (1983).
Seeman, P.Acta psychiatr. scand.82, (Suppl. 358), 14–20 (1990).
Seeman, P. & Niznik, H. B.ISI Atlas Sci. Pharmac.2, 161–170 (1988).
Seeman, P.et al.Eur. J. Pharmac.56, 247–251 (1979).
Stormann, T. M., Gdula, D. C., Weiner, D. M. & Brann, M. R.Molec. Pharmac.37, 1–6 (1990).
Giros, B.et al.Nature342, 923–926 (1989).
Sanchez-Roa, P. M.et al.Life Sci.45, 1821–1829 (1989).
Author information
Authors and Affiliations
Department of Pharmacology, University of Toronto, Medical Sciences Building, Toronto, Ontario, M5S 1A8, Canada
Hubert H. M. Van Tol, Hong-Chang Guan, Roger K. Sunahara, Philip Seeman & Hyman B. Niznik
Department of Psychiatry, University of Toronto, Medical Sciences Building, Toronto, Ontario, M5S 1A8, Canada
Hubert H. M. Van Tol, Philip Seeman & Hyman B. Niznik
Clarke Institute of Psychiatry, Laboratory for Molecular Neurobiology, Toronto, Ontario, M5T 1R8, Canada
Hubert H. M. Van Tol & Hyman B. Niznik
Vollum Institute for Advanced Biomedical Research, Department of Cell Biology and Anatomy, Oregon Health Sciences University, Portland, Oregon, 97201, USA
James R. Bunzow & Olivier Civelli
- Hubert H. M. Van Tol
You can also search for this author inPubMed Google Scholar
- James R. Bunzow
You can also search for this author inPubMed Google Scholar
- Hong-Chang Guan
You can also search for this author inPubMed Google Scholar
- Roger K. Sunahara
You can also search for this author inPubMed Google Scholar
- Philip Seeman
You can also search for this author inPubMed Google Scholar
- Hyman B. Niznik
You can also search for this author inPubMed Google Scholar
- Olivier Civelli
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Van Tol, H., Bunzow, J., Guan, HC.et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine.Nature350, 610–614 (1991). https://doi.org/10.1038/350610a0
Received:
Accepted:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative